Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Income from Continuing Operations (2016 - 2025)

Haemonetics (HAE) has 17 years of Income from Continuing Operations data on record, last reported at 44740000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 19.24% year-over-year to 44740000.0; the TTM value through Dec 2025 reached 175436000.0, up 34.87%, while the annual FY2025 figure was 167679000.0, 42.64% up from the prior year.
  • Income from Continuing Operations reached 44740000.0 in Q4 2025 per HAE's latest filing, up from 38684000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 57981000.0 in Q1 2025 and bottomed at 11041000.0 in Q2 2021.
  • Average Income from Continuing Operations over 5 years is 27522000.0, with a median of 32086500.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: tumbled 162.61% in 2021, then surged 551.32% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 14856000.0 in 2021, then soared by 121.76% to 32944000.0 in 2022, then dropped by 5.21% to 31229000.0 in 2023, then increased by 20.15% to 37521000.0 in 2024, then rose by 19.24% to 44740000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 44740000.0 in Q4 2025, 38684000.0 in Q3 2025, and 34031000.0 in Q2 2025.